Medical Properties Trust, Inc. (NYSE:MPW) was the recipient of some unusual options trading activity on Friday. Investors bought 510 call options on the company. This is an increase of Infinity compared to the average volume of 0 call options.

Shares of Medical Properties Trust (NYSE MPW) opened at $13.56 on Monday. The company has a debt-to-equity ratio of 1.26, a current ratio of 2.55 and a quick ratio of 2.06. The stock has a market cap of $4,937.96, a P/E ratio of 10.51, a price-to-earnings-growth ratio of 2.01 and a beta of 0.95. Medical Properties Trust has a one year low of $11.57 and a one year high of $14.22.

Medical Properties Trust (NYSE:MPW) last issued its quarterly earnings data on Thursday, November 2nd. The real estate investment trust reported $0.33 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.32 by $0.01. Medical Properties Trust had a net margin of 39.95% and a return on equity of 7.36%. The business had revenue of $176.60 million during the quarter, compared to analysts’ expectations of $172.57 million. During the same period in the previous year, the company earned $0.30 earnings per share. Medical Properties Trust’s revenue for the quarter was up 39.5% on a year-over-year basis. equities research analysts predict that Medical Properties Trust will post 1.31 EPS for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Thursday, January 11th. Stockholders of record on Thursday, December 7th will be paid a $0.24 dividend. This represents a $0.96 dividend on an annualized basis and a dividend yield of 7.08%. The ex-dividend date of this dividend is Wednesday, December 6th. Medical Properties Trust’s payout ratio is 126.32%.

A number of research analysts recently commented on the stock. ValuEngine raised shares of Medical Properties Trust from a “hold” rating to a “buy” rating in a research report on Thursday. SunTrust Banks, Inc. reaffirmed a “buy” rating and set a $15.00 price objective on shares of Medical Properties Trust in a research report on Friday, November 3rd. Zacks Investment Research raised shares of Medical Properties Trust from a “hold” rating to a “buy” rating and set a $15.00 price objective on the stock in a research report on Tuesday, October 24th. KeyCorp reaffirmed a “hold” rating on shares of Medical Properties Trust in a research report on Sunday, September 17th. Finally, Stifel Nicolaus reiterated a “hold” rating and issued a $13.00 target price on shares of Medical Properties Trust in a research note on Friday, July 28th. Two equities research analysts have rated the stock with a sell rating, six have assigned a hold rating and seven have issued a buy rating to the stock. Medical Properties Trust presently has an average rating of “Hold” and an average target price of $14.18.

Several institutional investors have recently modified their holdings of the company. Wells Fargo & Company MN lifted its stake in shares of Medical Properties Trust by 10.5% in the third quarter. Wells Fargo & Company MN now owns 2,959,090 shares of the real estate investment trust’s stock worth $38,852,000 after buying an additional 280,222 shares during the last quarter. Cadence Capital Management LLC acquired a new stake in shares of Medical Properties Trust in the third quarter worth $334,000. Evergreen Capital Management LLC lifted its stake in shares of Medical Properties Trust by 171.8% in the third quarter. Evergreen Capital Management LLC now owns 267,000 shares of the real estate investment trust’s stock worth $3,506,000 after buying an additional 168,750 shares during the last quarter. Schroder Investment Management Group lifted its stake in shares of Medical Properties Trust by 115.9% in the third quarter. Schroder Investment Management Group now owns 254,155 shares of the real estate investment trust’s stock worth $3,301,000 after buying an additional 136,436 shares during the last quarter. Finally, JPMorgan Chase & Co. lifted its stake in shares of Medical Properties Trust by 157.1% in the third quarter. JPMorgan Chase & Co. now owns 641,841 shares of the real estate investment trust’s stock worth $8,338,000 after buying an additional 392,227 shares during the last quarter. Institutional investors and hedge funds own 84.01% of the company’s stock.

TRADEMARK VIOLATION WARNING: This piece was originally posted by American Banking News and is owned by of American Banking News. If you are accessing this piece on another domain, it was copied illegally and reposted in violation of United States & international copyright laws. The correct version of this piece can be read at https://www.americanbankingnews.com/2017/11/13/medical-properties-trust-sees-unusually-high-options-volume-mpw.html.

Medical Properties Trust Company Profile

Medical Properties Trust, Inc is a real estate investment trust (REIT). The Company focuses on investing in and owning net-leased healthcare facilities across the United States and selectively in foreign jurisdictions. The Company’s segment is its investments in healthcare real estate, including mortgage and other loans, as well as any equity investments in its tenants.

Receive News & Ratings for Medical Properties Trust Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust Inc. and related companies with MarketBeat.com's FREE daily email newsletter.